1. Home
  2. MGIH vs PULM Comparison

MGIH vs PULM Comparison

Compare MGIH & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Millennium Group International Holdings Limited

MGIH

Millennium Group International Holdings Limited

HOLD

Current Price

$1.31

Market Cap

17.3M

ML Signal

HOLD

Logo Pulmatrix Inc.

PULM

Pulmatrix Inc.

HOLD

Current Price

$4.43

Market Cap

14.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGIH
PULM
Founded
1978
2003
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.3M
14.9M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MGIH
PULM
Price
$1.31
$4.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
40.7K
9.5K
Earning Date
10-28-2025
10-16-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$25,334,149.00
$3,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$134.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.11
$3.90
52 Week High
$6.83
$10.40

Technical Indicators

Market Signals
Indicator
MGIH
PULM
Relative Strength Index (RSI) 42.54 49.50
Support Level $1.36 $3.95
Resistance Level $1.82 $4.48
Average True Range (ATR) 0.15 0.32
MACD 0.02 0.01
Stochastic Oscillator 12.07 50.96

Price Performance

Historical Comparison
MGIH
PULM

About MGIH Millennium Group International Holdings Limited

Millennium Group International Holdings Ltd supplies paper-based packaging solutions, including inner packaging boxes produced with offset or flexo printing and outer corrugated boxes used for transportation, storage, pallets, and point-of-purchase displays. The company manufactures corrugated products of different sizes, shapes, thicknesses, and strengths according to customer specifications. It also operates a supply chain management business in Vietnam to service international clients who source their packaging needs from Vietnam and other ASEAN countries. The corrugated paper is durable, versatile, economical, and lightweight.

About PULM Pulmatrix Inc.

Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).

Share on Social Networks: